Verifi^TM Prenatal Screen

Verifi^™ Plus-Responsibly Expanding the Accurate, Reliable, and Relevant Verifi^™

The  Verifi™ Plus for singleton pregnancies  screens for Down syndrome, Trisomy 18, Trisomy 13 and additional options that you and your healthcare provider may choose  to select, as shown below:

• Select microdeletions such as 1p36 deletion, 4p- (Wolf-Hirschhorn syndrome), 5p- (cri-du-chat syndrome), 15q11.2 (Prader-Willi syndrome/Angelman syndrome), and 22q11.2 deletion (DiGeorge syndrome)
• Sex chromosome aneuploidies (monosomy X, XXX, XXY, and XYY) are included if requested; fetal sex (XX or  XY) will be reported if no sex chromosome aneuploidy is detected.
• Aneuploidy (trisomy) of all chromosomes, including sex chromosome aneuploidies.

How It Works

A  sample  of your  blood is drawn  and the genetic material  (DNA) from your baby is tested.  Verifi™ takes a deeper approach to  the science, using an advanced technology  called “Whole Genome Sequencing” to analyze millions of DNA fragments per sample and accurately count the number of chromosomes present.

Test Results

Turn around time: Results can be expected 5-8 business days from the time the sample is received at the laboratory.

About Illumina

Illumina is a leading developer, manufacturer, and marketer of life science tools and integrated systems for large-scale analysis of genetic variation and function. These systems are enabling studies that were not even imaginable just a few years ago, and moving us closer to the realization of personalized medicine. With rapid advances in technology taking place, it is mission-critical to offer solutions that are not only innovative, but flexible, and scalable, with industry-leading support and service. They strive to meet this challenge by placing a high value on collaborative interactions, rapid delivery of solutions, and meeting the needs of our customers.